Artivion (AORT) has a profit margin of -0.67%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for AORT is -0.67% as of June 2026. That compares with -4.43% in the prior-year period — up 84.8% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Artivion's historical trend and sector peers before judging valuation or financial health.
Over the past year, AORT's profit margin moved from -4.43% to -0.67% — a 84.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Artivion's valuation or profitability profile.
Against Healthcare companies, AORT currently prints -0.67% for profit margin, while the sector average sits near 21.34%. That is roughly 103.1% below the sector mean. Large gaps often invite a closer look at Artivion's growth, margins, and balance sheet.
Profit Margin shows how effectively Artivion converts resources into returns. At -0.67%, AORT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4.43% in the prior-year period — up 84.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AORT's profit margin (-0.67%), review year-over-year change from -4.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.